In line with these findings, delta‐like protein 3 (DLL3) protein, an inhibitory Notch pathway ligand,60 was expressed in decreasing amounts from SCLC‐A to SCLC‐Y, indicating the Notch pathway's gradual activation (Figure S2c). The gene discussed is DLL3; the disease is small cell lung carcinoma.